| Size & multiples | |||
| Market Cap | $1.64B | Enterprise Value | $1.83B |
| P/E (TTM) | 45.69× | PEG (trailing) | — |
| P/S | 0.75× | P/FCF | 14.28× |
| EV/EBITDA | 437.15× | EV/EBIT | — |
| EV/Sales | 0.84× | EV/FCF | 15.89× |
| FCF Yield | 7.00% | Buyback Yield | 1.53% |
| Owner Earnings (TTM) | $65.1M | Owner Earnings Yield | 3.97% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 0.24 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 5.20% |
| After-tax Cost of Debt | — | WACC | — |
| ROIC | −47.25% | EVA Spread (ROIC−WACC) | — |
| EVA | — | ||
FCF runs above owner earnings — under-maintenance or a working-capital release is flattering current cash.
Flows TTM (last 4 quarters) · EPS TTM $0.34 · revenue TTM $2.18B · FCF TTM $114.9M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| FCF Yield | -18.7% | -7.9% | -35.6%–1.4% | 36 ↓weak |
| Net Margin | -32.5% | -21.2% | -325.3%–7.2% | 46 ↓weak |
| Operating Margin | -31.8% | -34.5% | -552.0%–8.0% | 51 ↑strong |
| ROE | -53.5% | -36.8% | -92.5%–4.5% | 40 ↓weak |
